FDA has approved pancrelipase for adult and pediatric patients with exocrine pancreatic insufficiency (EPI) due to cystic fibrosis (CF), chronic pancreatitis, and other conditions.
- Questions and Answers for Healthcare Professionals and the Public: Switching to an Approved Pancreatic Enzyme Product (PEP)
- FDA Approves Pancreatic Enzyme Product, Pancreaze
- FDA Response to Creon Citizen Petition
- Questions and Answers: Delayed-Release Pancreatic Enzyme Product Receives FDA Approval